Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
Core EBITDA Growth

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 7.7642.48-15.611.9932.11

What is the latest Core EBITDA Growth ratio of AJANTA PHARMA ?

The latest Core EBITDA Growth ratio of AJANTA PHARMA is 7.76 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20257.76
Mar202442.48
Mar2023-15.61
Mar20221.99
Mar202132.11

How is Core EBITDA Growth of AJANTA PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 7.76
-81.73
Mar2024 42.48
Positive
Mar2023 -15.61
Negative
Mar2022 1.99
-93.80
Mar2021 32.11 -

Other Financial Ratios of AJANTA PHARMA


Compare Core EBITDA Growth ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹34,255.7 Cr 5.5% 9.3% -6.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,884.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹172,442.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,770.0 Cr 1.3% 2.7% 10% Stock Analytics
CIPLA ₹120,871.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,693.0 Cr -1% 2.5% -4.4% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

5.5%

9.3%

-6.5%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses